Dr. Frampton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# Box
Rochester, NY 14642Phone+1 585-275-4861Fax+1 585-273-1058
Education & Training
- University of RochesterFellowship, Pulmonary Disease and Critical Care Medicine, 1985 - 1988
- University at BuffaloResidency, Internal Medicine, 1973 - 1976
- New York University School of MedicineClass of 1973
Certifications & Licensure
- NY State Medical License 1974 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Ozone Cardiovascular Effects in Genetically Susceptible People Start of enrollment: 2011 May 01
- Cardiovascular Effects of Exposure to Ozone Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- Do Ultrafine Particles Carry Any Weight When It Comes to Progression of Pulmonary Fibrosis?Mark W Frampton
American Journal of Respiratory and Critical Care Medicine. 2024-05-01 - 8 citationsDo Ambient Ozone or Other Pollutants Modify Effects of Controlled Ozone Exposure on Pulmonary FunctionDavid Q. Rich, Sally W. Thurston, John R. Balmes, Philip A. Bromberg, Mehrdad Arjomandi
Annals of the American Thoracic Society. 2020-05-01 - 2 citationsMulticenter Ozone Study in oldEr Subjects (MOSES): Part 2. Effects of Personal and Ambient Concentrations of Ozone and Other Pollutants on Cardiovascular and Pulmonary...David Q. Rich, Mark W. Frampton, John R. Balmes, Philip A. Bromberg, Mehrdad Arjomandi
Research Report. 2020-03-01
Journal Articles
- Cardiovascular Function and Ozone Exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES)John R. Balmes, Philip A. Bromberg, Mark W. Frampton, Mehrdad Arjomandi, ScienceDirect
Press Mentions
- Sugar Companies Say the Air Is SafeJuly 8th, 2021
- Policy News: June 28, 2021June 28th, 2021
- EPA Chief Reinstates Scientific Advisory Board He Disbanded – US News & World ReportJune 18th, 2021
- Join now to see all
Grant Support
- Ozone Cardiovascular Effects In Genetically Susceptible PeopleNational Institute Of Environmental Health Sciences2010–2012
- Multidisciplinary Training In Pulmonary ResearchNational Heart, Lung, And Blood Institute2001–2011
- Cardiovascular Effects Of Ultrafine Particles In Genetically Susceptible SubjectsNational Institute Of Environmental Health Sciences2009–2010
- Ultrafine Particle-Induced Oxidative StressNational Institute Of Environmental Health Sciences2004–2007
- Exposure To Ultrafine Carbon Particles In Diabetes (UPDIABETES)National Center For Research Resources2005
- Effects Of Particle Exposure On The Pulmonary Diffusing Capacity (UPDLCO)National Center For Research Resources2004–2005
- Ultrafine Particle Exposure In HumansNational Institute Of Environmental Health Sciences2002–2005
- Effects Of Exposure To 50ug/M3 Ultrafine Carbon Particles In Healthy SubjectsNational Center For Research Resources2004
- Effects Of Breathing Ultrafine Particles At RESTNational Center For Research Resources2000–2002
- Dose Response To Ultra FINE Carbon Particles W/ ExerciseNational Center For Research Resources2000–2002
- Airway Effects Of Repeated Exposures To Ozone In Healthy And AsthmaticsNational Center For Research Resources1996–2001
- AIR Pollution On Breathing Assessed By Lung Lavage In Healthy HumansNational Center For Research Resources1996–2001
- Oxidant AIR Pollutants, Airway Inflammation, And Respiratory Host DefenseNational Institute Of Environmental Health Sciences1996–2000
- Human Health Effects Of Repeated Exposures To OzoneNational Heart, Lung, And Blood Institute1993–1996
- Mechanisms Of Airway Inflammation With Varying Responses To OzoneNational Center For Research Resources1992–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: